Dr Reddys Laboratories (RDY) Other Operating Expenses (2009 - 2026)

Dr Reddys Laboratories has reported Other Operating Expenses for 18 years, with the latest figure at -$8.8 million in Q2 2026.

• On a quarterly basis, Other Operating Expenses fell 1.53% year-over-year to -$8.8 million in Q2 2026; TTM through Jun 2026 was $152.6 billion, a 117.6% increase from a year earlier, with the FY2026 full-year figure at $81.0 million, up 58.82% from the prior year.
• Other Operating Expenses was -$8.8 million for Q2 2026 at Dr Reddys Laboratories, down from $77.9 billion in the prior quarter.
• The five-year high for Other Operating Expenses was $77.9 billion in Q1 2026, with the low at -$78.1 million in Q2 2022.
• Average Other Operating Expenses over 5 years is $12.4 billion, with a median of -$5.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Other Operating Expenses sank 385.96% in 2022, then jumped 1418913.56% in 2025.
• Over 5 years, Other Operating Expenses stood at -$3.0 million in 2022, then sank by 243.08% to -$10.3 million in 2023, then soared by 49.02% to -$5.2 million in 2024, then surged by 1418913.56% to $74.4 billion in 2025, then plunged by 100.01% to -$8.8 million in 2026.
• The last three Other Operating Expenses figures came in at -$8.8 million (Q2 2026), $77.9 billion (Q1 2026), and $74.4 billion (Q4 2025), per Business Quant data.